Johnson Matthey PLC (LON:JMAT – Get Free Report) insider Liam Condon purchased 24 shares of the stock in a transaction on Wednesday, April 17th. The shares were bought at an average cost of GBX 1,767 ($22.00) per share, for a total transaction of £424.08 ($527.92).
Johnson Matthey Stock Performance
Shares of LON JMAT opened at GBX 1,788 ($22.26) on Friday. The company has a current ratio of 1.51, a quick ratio of 0.76 and a debt-to-equity ratio of 63.95. Johnson Matthey PLC has a 12 month low of GBX 1,428.50 ($17.78) and a 12 month high of GBX 1,984 ($24.70). The stock has a 50 day moving average of GBX 1,706.43 and a 200-day moving average of GBX 1,627.65. The company has a market capitalization of £3.28 billion, a P/E ratio of 1,862.50, a P/E/G ratio of 49,242.50 and a beta of 0.98.
Wall Street Analyst Weigh In
Several research firms have weighed in on JMAT. Jefferies Financial Group reaffirmed a “buy” rating and set a GBX 2,100 ($26.14) price target on shares of Johnson Matthey in a research report on Wednesday, March 20th. Berenberg Bank boosted their price target on Johnson Matthey from GBX 1,650 ($20.54) to GBX 1,800 ($22.41) and gave the stock a “hold” rating in a research report on Monday, April 8th. Finally, Numis Securities reaffirmed a “buy” rating and set a GBX 2,200 ($27.39) price target on shares of Johnson Matthey in a research report on Wednesday, March 20th. One research analyst has rated the stock with a sell rating, one has issued a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, Johnson Matthey has an average rating of “Moderate Buy” and an average target price of GBX 2,010 ($25.02).
Johnson Matthey Company Profile
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
Recommended Stories
- Five stocks we like better than Johnson Matthey
- Consumer Staples Stocks, Explained
- MarketBeat Week in Review – 4/15 – 4/19
- Upcoming IPO Stock Lockup Period, Explained
- Comprehensive Analysis of PayPal Stock
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Intuitive Surgical Stock Can Trend Much Higher This Year
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.